Your prediction
Takeda Pharmaceutical Co Ltd Stock
The Takeda Pharmaceutical Co Ltd stock is trending slightly upwards today, with an increase of €0.19 (0.600%) compared to yesterday's price.
For the coming years our community has positive and negative things to say abot the Takeda Pharmaceutical Co Ltd stock. Criterium "Business model" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Takeda Pharmaceutical Co Ltd in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Takeda Pharmaceutical Co Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Co Ltd | 0.600% | 1.143% | 1.079% | 15.902% | 21.844% | 5.324% | 1.207% |
| Eisai Co Ltd | 2.730% | 5.267% | -1.570% | 7.608% | 8.157% | -47.124% | -52.035% |
| Chugai Pharmaceutical Co Ltd | 3.130% | 9.976% | -11.190% | 18.947% | 11.442% | 123.929% | 44.971% |
| Santen Pharmaceutical Corp Ltd. | -0.500% | 6.452% | 6.452% | 14.451% | 13.793% | 29.412% | -15.385% |
Comments
News
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Next Steps in its Transformation to Strengthen Competitiveness and Accelerate Future Growth Outlook
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Next Steps in its Transformation to Strengthen Competitiveness and Accelerate Future Growth Outlook
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)